The interactions between opioids and gabapentin are more clinically relevant than ever. Prescriptions dispensed for gabapentin increased from 39 million in 2012 to 64 million in 2018 in the USA and are ever increasing. Authors present a challenging case of these interactions. A 58-year-old man presented to the emergency department with acute respiratory failure and altered mental status. He was on high dose opioids and gabapentin as prescription medications. Despite full intensive care support and resolution of his respiratory failure with non-invasive positive pressure ventilation, the patient did not regained consciousness. After ruling out other causes, the diagnosis of gabapentin withdrawal was considered. Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms. We concluded that severe gabapentin withdrawal should be considered in patients on higher doses of gabapentin when it is stopped abruptly. In such patients, gabapentin should be replaced. As most patients are unable to swallow in this situation and intravenous formulation is not available, nasogastric tube can be used for replacement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506108PMC
http://dx.doi.org/10.1136/bcr-2018-228354DOI Listing

Publication Analysis

Top Keywords

opioids gabapentin
12
gabapentin
9
respiratory failure
8
gabapentin withdrawal
8
withdrawal considered
8
nasogastric tube
8
complex encephalopathy
4
encephalopathy arising
4
arising combination
4
combination opioids
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!